Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ana Rosa Cid-Haro"'
Autor:
Pedro Asensi Cantó, Mercedes Rodríguez Serna, Pilar Lloret Madrid, Jürgen Solís Ruiz, Ana Rosa Cid Haro, Santiago Bonanad Boix, Saturnino Haya Guaita
Publikováno v:
TH Open, Vol 06, Iss 03, Pp e154-e155 (2022)
Emicizumab constitutes a novel and effective prophylaxis for hemophilia A patients with and without inhibitors. In this case report, we describe an emicizumab-induced photosensitivity that forced permanent sun-exposure suppression. To the best of our
Externí odkaz:
https://doaj.org/article/8abcd50deece4e32bc4645dbde3199ce
Autor:
Pedro Asensi Cantó, Mercedes Rodríguez Serna, Pilar Lloret Madrid, Jürgen Solís Ruiz, Ana Rosa Cid Haro, Santiago Bonanad Boix, Saturnino Haya Guaita
Publikováno v:
TH open : companion journal to thrombosis and haemostasis. 6(3)
Emicizumab constitutes a novel and effective prophylaxis for hemophilia A patients with and without inhibitors. In this case report, we describe an emicizumab-induced photosensitivity that forced permanent sun-exposure suppression. To the best of our
Autor:
Mariana Isabel Canaro-Hirnyk, Ana Rosa Cid-Haro, Carmen Altisent-Roca, María Teresa Álvarez-Román, Carmen Sedano-Balbas, Maria Eva Mingot-Castellano, Rosario Pérez-Garrido, Víctor Jiménez-Yuste, María Fernanda López-Fernández
Publikováno v:
European Journal of Haematology. 96:461-474
Introduction Patients with severe haemophilia and inhibitors against factor VIII who require surgery need a prophylactic approach to prevent bleeding complications. Scientific evidence to decide the best prophylactic treatment is very limited and mai
Autor:
María Teresa Álvarez-Román, Ana Rosa Cid Haro, Carmen Sedano Balbas, Víctor Jiménez-Yuste, Mariana Isabel Canaro Hirnyk, Rosario Pérez-Garrido, Carmen Altisent Roca, Maria Eva Mingot-Castellano, María Fernanda López-Fernández
Publikováno v:
Thrombosis and Haemostasis. 115:872-895
SummaryProphylaxis with the blood clotting factor, factor VIII (FVIII) is ineffective for individuals with haemophilia A and high-titre inhibitors to FVIII. Prophylaxis with the FVIII bypassing agents activated prothrombin complex concentrates (aPCC;
Autor:
Brigit Brand, Alessandro Gringeri, Paul Giangrande, James J. Goedert, Michael Recht, Olga Katsarou, Ana Rosa Cid-Haro, Patrick F. Fogarty, Steven M. Wolinsky, Evelien P. Mauser-Bunschoten, Judith Lin, Kate Talks, Javier Martinez-Picado, Amy D. Shapiro, Amalio Telenti, Christine L. Kempton, Lucy Dorrell, David Goldstein, Jérôme Lane, Jerry S. Powell, Sara Colombo, Judith Dalmau, Jeremy J. Martinson, Johannes Oldenburg, Shehnaz K. Hussain, Barton F. Haynes, Michael Makris, Dimitrios A. Tsakiris, Amanda Stemke, Anne T. Neff, Stephen Moore, Shinichi Oka, Philip Kuriakose, Rathi V. Iyer, Jonathan T. Wilde, Peter William Collins, Maria Teresa Alvarez-Roman, Andrew J. McMichael, Rafael Parra, Françoise Boehlen, Paul J. McLaren, Deborah L Brown, Marilyn J. Manco-Johnson, Thynn Thynn Yee, Kimo C. Stine, Bonaventura Clotet, Kimberly Pelak, Jay H. Bream, Kristiina Peter-Salonen, Paula H B Bolton-Maggs, Elaine Y. Chiang, Lisa P. Jacobson, Mary Carrington, Lara Oyesiku, Anne Angelillo-Scherrer, Jacques Fellay, Kevin V. Shianna
Publikováno v:
Lane, Jérôme; McLaren, Paul J.; Dorrell, Lucy; Shianna, Kevin V.; Stemke, Amanda; Pelak, Kimberly; Moore, Stephen; Oldenburg, Johannes; Boehlen, Francoise; Alvarez-Roman, Maria Teresa; Angelillo-Scherrer, Anne; Bolton-Maggs, Paula H. B.; Brand, Brigit; Brown, Deborah; Chiang, Elaine; Cid-Haro, Ana Rosa; Clotet, Bonaventura; Collins, Peter; Colombo, Sara; Dalmau, Judith; ... (2013). A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Human molecular genetics, 22(9), pp. 1903-1910. Oxford University Press 10.1093/hmg/ddt033
Human Molecular Genetics, Vol. 22, No 9 (2013) pp. 1903-1910
Human molecular genetics
Human Molecular Genetics, vol. 22, no. 9, pp. 1903-1910
Human Molecular Genetics, Vol. 22, No 9 (2013) pp. 1903-1910
Human molecular genetics
Human Molecular Genetics, vol. 22, no. 9, pp. 1903-1910
Human genetic variation contributes to differences in susceptibility to HIV-1 infection. To search for novel host resistance factors, we performed a genome-wide association study (GWAS) in hemophilia patients highly exposed to potentially contaminate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1c24750bfdac52d92b3d5e567a3f03
https://doi.org/10.1093/hmg/ddt033
https://doi.org/10.1093/hmg/ddt033